Argent BioPharma (RGT) Share Price, News & Analysis

Company Overview

Argent Biopharma is a clinical stage, revenue generating biopharmaceutical company committed to providing accessible medical treatments for unmet medical needs. The Group focuses on the multidisciplinary method, especially relating to the Central nervous system (“CNS”) and Immunology treatments

Key Stats

• Today's Range: N/A
• 50-Day Range: 5.50 to 15.10
• 52-Week Range: N/A
• Volume: 24,715 shs
• Average Volume: 11,475 shs
• Market Capitalization: £8.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RGT Stock Analysis - Frequently Asked Questions

How do I buy shares of Argent BioPharma?

Shares of RGT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: LON:RGT
• CIK: N/A
• Web: argentbiopharma.com
• Phone: 61-8-6555-2950
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.24)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-17,530,000.00
• Net Margins: -1,960.39%
• Pretax Margin: N/A
• Return on Equity: 420.08%
• Return on Assets: -108.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.23
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: GBX (11.44) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 53,610,000
• Free Float: N/A
• Market Cap: £8.31 million
• Optionable: N/A
• Beta: 1.05